Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up  |  Already a member? Sign In  |  Visit IQPC.com  
Pharma IQ


Pharma 2020: Which path will you take?

 This FREE webinar was recorded on:
Thursday, November 22, 2012,
8:00 AM - 9:00 AM EST

Register
Knowledge Partner



Learn how to sponsor a webinar with us?

Tags: Pharma 2020: The Vision | PwC | PriceWaterHouse Cooper | blockbuster sales model | supply chain


By 2020 the pharmaceutical market is anticipated to more than double to US$1.3 trillion, with the E7 countries — Brazil, China, India, Indonesia, Mexico, Russia and Turkey — accounting around for one fifth of global pharmaceutical sales. Further, incidence of chronic conditions in the developing world will increasingly resemble those of the developed world.
 
"Pharma 2020: The vision: Which path will you take" indicates that the current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates.
 
Some of the major changes PwC anticipates for the industry are:
  • Health care will shift in focus from treatment to prevention
  • Pharmaceutical companies will provide total health care packages
  • The current linear phase research & development process will give way to in-life testing and live licensing, in collaboration with regulators and health care providers
  • The traditional blockbuster sales model will disappear
  • The supply chain function will become revenue generating as it becomes integral to the health care package and enables access to new channels
  • More sophisticated direct-to-consumer distribution channels will diminish the role of wholesalers

Click here for more information on the Pharma 2020 Vision



Presenter:

Steve Arlington
Steve Arlington
Global Advisory Leader Pharmaceuticals & Life Sciences
PricewaterhouseCoopers

Steve leads the global advisory team at PwC focussed on the pharmaceutical and life sciences industry. Based in London, he has worked in the industry for over 13 years and has consulted to both pharmaceutical and biotech companies for 17 years.

He specialises in the areas of strategy, discovery research, new product and process development, boardroom strategy and transformation.
Steve has a BSc, PhD and is a visiting professor at UCL. He has been a faculty member of the ECPM for 12 years and is a member of the Royal Society of Medicine and the DIA.


Selected Experience

  • Steve has led the firms forward thinking thought leadership series Pharma 2005, Pharma 2010 and currently leads the Pharma 2020 series. These papers have been met with widespread acclaim across the industry.
  • Steve has led complex assignments for almost all of the major pharmaceutical players; he has worked extensively across Europe, USA and Japan and more recently in the growing markets of Asia.
  • Steve works across the value chain of the Pharma company and regulators across the world.
     
Areas of Expertise
Pharma R&D, Strategy, Cost Effectiveness, Futures analysis, and Transformation
 


To view this FREE Webinar register here.
Already a member of Pharma IQ? Sign in to register.

First Name:  *
Last Name:  *
Job Title:  *
E-mail:  *
Phone:  *
Company:  *
Country:
User Name:  *
Password:  *
Confirm Password:  *
Which of the following best describes your area of expertise?

Be the first to leave a comment
Sign in or Sign up to post a comment
Advertisement

Recent Activity

* = required.

Not a member yet? Sign up
User Name:
Password: